City
Epaper

Explained: Why are some people more resilient to Covid-19?

By IANS | Updated: July 2, 2021 18:55 IST

New York, July 2 Many people experienced serious Covid-19 infection leading to hospitalisation and even death, while some ...

Open in App

New York, July 2 Many people experienced serious Covid-19 infection leading to hospitalisation and even death, while some people escaped with milder symptoms.

The reason: They had prior run-ins with other coronaviruses the ones that cause about a quarter of the common colds kids get, according to a study.

Researchers from the Stanford University in the US showed that in such people, the immune cells are better equipped to mobilise quickly against SARS-CoV-2, the virus responsible for Covid-19.

The immune cells, called killer T-cells, roam through the blood and lymph, park in tissues and carry out stop-and-frisk operations on resident cells.

The study, published in the journal Science Immunology, showed that killer T-cells taken from the sickest Covid-19 patients exhibit fewer signs of having had previous run-ins with common-cold-causing coronaviruses.

Many of these killer T cells were in "memory" mode, said Mark Davis, Professor of microbiology and immunology at the Stanford's School of Medicine.

"Memory cells are by far the most active in infectious-disease defense. They're what you want to have in order to fight off a recurring pathogen. They're what vaccines are meant to generate," Davis said.

For the study, the team analysed blood samples taken from healthy donors before the Covid-19 pandemic began, meaning they'd never encountered SARS-CoV-2 although many presumably had been exposed to common-cold-causing coronavirus strains.

They found that Covid-19 patients with milder symptoms tended to have lots of killer-T memory cells directed at peptides SARS-CoV-2 shared with other coronavirus strains.

Sicker patients' expanded killer T-cell counts were mainly among those T-cells typically targeting peptides unique to SARS-CoV-2 and, thus, probably had started from scratch in their response to the virus.

"It may be that patients with severe Covid-19 hadn't been infected, at least not recently, by gentler coronavirus strains, so they didn't retain effective memory killer T cells," Davis said.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Current Protocols in Molecular BiologyMark davisStanford UniversityNational academics of sciences
Open in App

Related Stories

TechnologyResearch identifies subtype of depression

EntertainmentSarah Jessica Parker gives nod to late friend and 'Sex and the City' co-star Willie Garson

NationalNot seeking any int'l support, our fight is ours: Rahul at Stanford

PoliticsRahul Gandhi arrives in San Francisco

NationalCongress leader Rahul Gandhi arrives in San Francisco as part of his 10-day US tour

Health Realted Stories

HealthTN school reopening decision will depend on heatwave conditions: Minister

HealthGlobal recognition of Yoga testament to India’s rich cultural heritage: Ayush Minister

HealthGujarat beneficiaries of Ayushman Bharat gettting life-saving medical treatments without financial strain

HealthNHRC asks 11 states to boost measures to prevent heat-related deaths

HealthDiabetes drug can effectively treat fatty liver: Study